The 7th Annual Evercore
HealthCONx Conference on December
3
Citi's 2024 Global Healthcare Conference on
December 4
SAN
DIEGO, Nov. 26, 2024 /PRNewswire/ -- Neurocrine
Biosciences, Inc. (Nasdaq: NBIX) will participate at two upcoming
investor conferences in December. Chief Executive Officer
Kyle Gano, Chief Financial Officer
Matt Abernethy, and Vice-President
of Investor Relations Todd Tushla
will present at:
- The 7th Annual Evercore HealthCONx Conference at
10:50 a.m. Eastern Time on Tuesday
December 3, 2024 in Coral Gables,
Florida.
- Citi's 2024 Global Healthcare Conference at 1:45 p.m. Eastern Time on Wednesday December 4,
2024 in Miami.
The live presentations will be webcast and may be accessed on
Neurocrine Biosciences' website under Investors at
www.neurocrine.com. A replay of the webcasts will be available on
the website approximately one hour after the conclusion of the
events and will be archived for approximately one month.
About Neurocrine Biosciences
Neurocrine Biosciences is
a leading neuroscience-focused, biopharmaceutical company with a
simple purpose: to relieve suffering for people with great needs,
but few options. We are dedicated to discovering and developing
life-changing treatments for patients with under-addressed
neurological, neuroendocrine, and neuropsychiatric disorders. The
company's diverse portfolio includes FDA-approved treatments for
tardive dyskinesia, chorea associated with Huntington's disease,
endometriosis* and uterine fibroids*, as well as a robust pipeline
including multiple compounds in mid- to late-phase clinical
development across our core therapeutic areas. For three decades,
we have applied our unique insight into neuroscience and the
interconnections between brain and body systems to treat complex
conditions. We relentlessly pursue medicines to ease the burden of
debilitating diseases and disorders, because you deserve brave
science. For more information, visit neurocrine.com, and
follow the company on LinkedIn, X (Formerly Twitter) and Facebook.
(*in collaboration with AbbVie)
NEUROCRINE BIOSCIENCES, NEUROCRINE, and YOU DESERVE BRAVE
SCIENCE are registered trademarks of Neurocrine Biosciences, Inc.
The Neurocrine logo is a trademark of Neurocrine Biosciences,
Inc.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/neurocrine-biosciences-to-participate-at-investor-conferences-in-december-302316899.html
SOURCE Neurocrine Biosciences, Inc.
